Incyte
INCY
#1188
Rank
โ‚ฌ17.07 B
Marketcap
85,81ย โ‚ฌ
Share price
-0.06%
Change (1 day)
21.45%
Change (1 year)

Incyte (INCY) - Cash on Hand

Cash on Hand as of December 2025 : โ‚ฌ3.03 Billion

According to Incyte's latest financial reports the company has โ‚ฌ3.03 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Incyte - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31โ‚ฌ3.04 B46.97%
2024-12-31โ‚ฌ2.07 B-37.29%
2023-12-31โ‚ฌ3.30 B9.53%
2022-12-31โ‚ฌ3.01 B45.63%
2021-12-31โ‚ฌ2.07 B41.58%
2020-12-31โ‚ฌ1.46 B-22.52%
2019-12-31โ‚ฌ1.89 B50.35%
2018-12-31โ‚ฌ1.25 B28.98%
2017-12-31โ‚ฌ0.97 B26.82%
2016-12-31โ‚ฌ0.76 B18.75%
2015-12-31โ‚ฌ0.64 B31.16%
2014-12-31โ‚ฌ0.49 B33.91%
2013-12-31โ‚ฌ0.36 B113.44%
2012-12-31โ‚ฌ0.17 B-19.22%
2011-12-31โ‚ฌ0.21 B-32.97%
2010-12-31โ‚ฌ0.31 B-2.88%
2009-12-31โ‚ฌ0.32 B131.8%
2008-12-31โ‚ฌ0.14 B-19.35%
2007-12-31โ‚ฌ0.17 B-27.26%
2006-12-31โ‚ฌ0.24 B-17.09%
2005-12-31โ‚ฌ0.29 B-15.91%
2004-12-31โ‚ฌ0.34 B48.4%
2003-12-31โ‚ฌ0.23 B-43.14%
2002-12-31โ‚ฌ0.41 B-28.64%
2001-12-31โ‚ฌ0.57 B-6.94%
2000-12-31โ‚ฌ0.61 B829.54%
1999-12-31โ‚ฌ66.48 M-29.05%
1998-12-31โ‚ฌ93.7 M100%
1997-12-31โ‚ฌ46.85 M631.58%
1996-12-31โ‚ฌ6.4 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novartis
NVS
โ‚ฌ9.77 B 222.10%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚ฌ12.69 B 318.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ6.15 B 102.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ8.00 B 163.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.57 B-81.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
โ‚ฌ0.32 B-89.37%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚ฌ50 M-98.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
โ‚ฌ65.58 M-97.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
โ‚ฌ0.20 B-93.22%๐Ÿ‡บ๐Ÿ‡ธ USA